2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$155.69+$2.12 (+1.38%)
Price as of Oct 22, 2026 7:59 PM EDT- $190.4BMarket Cap
- 29.56%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$155.69+$2.12 (+1.38%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $153.57 | ||
Change | -$2.94 (-1.88%) | ||
Open | $154.73 | ||
High | $155.42 | ||
Low | $151.71 | ||
Previous Close | $153.57 | ||
Volume | 6,210,519 | ||
30-Day Average Volume | 5,699,803 | ||
1-Week Change | 0.02% | ||
1-Month Change | 2.00% | ||
1-Year Change | 29.56% | ||
3-Year Change | 116.96% | ||
5-Year Change | 173.93% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $49.4B | ||
Market Cap | $190.4B | ||
Enterprise Value | $213.5B | ||
Period: QTR TTM FY | |||
Revenue | $7.6B | ||
Net Income | -$10.5B | ||
Free Cash Flow | $3.4B | ||
EBIT | -$10.3B | ||
EBITDA | -$10.2B | ||
Net Working Capital | $2.9B | ||
EPS | -$8.45 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 16 | ||
P/E | -18 | ||
PEG | 0 | ||
Price/Free Cash Flow | 55 | ||
Price/Operating Cash Flow | 53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.14% | ||
Trailing Annual Dividend Yield | 2.12% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield